Literature DB >> 1372514

Stable target-sensitive immunoliposomes.

P Pinnaduwage1, L Huang.   

Abstract

Interaction of immunoliposomes composed of dioleoylphosphatidylethanolamine (DOPE) (80%), dioleoylphosphatidic acid (DOPA) (20%), and a small amount of specific antibody with Herpes Simplex virus (HSV) were studied by detecting the immune-dependent lysis of liposomes. DOPA was used as the principal stabilizer of the immunoliposomes. Antibodies conjugated with N-glutarylphosphatidylethanolamine or oxidized GM1 served as the target-specific ligands of immunoliposomes. These immunoliposomes (d = 160-180 nm) were stable for at least one month when stored at 4 degrees C. However, they undergo a rapid aggregation and lysis reaction in the presence of a membrane-bound target such as intact HSV virions. We have also employed epitope peptide-containing liposomes (target liposomes) to mimic the virus and showed that the immunoliposomes could be aggregated and lysed by the target liposomes in an antigen-dependent manner. Immunoliposome lysis could be accelerated by increasing the incubation temperature to 60-70 degrees C. No immunoliposome lysis was observed if the target liposomes were absent, indicating the prolonged stability of the immunoliposomes. Liposome lysis was always accompanied by liposome aggregation. However, the aggregation-induced liposome destabilization is unique to the HII phase-forming lipids such as DOPE. DOPC-containing immunoliposomes did not lyse despite the fact that massive liposome aggregation had taken place.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372514     DOI: 10.1021/bi00126a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

Review 1.  Membrane adhesion and the formation of heterogeneities: biology, biophysics, and biotechnology.

Authors:  V D Gordon; T J O'Halloran; O Shindell
Journal:  Phys Chem Chem Phys       Date:  2015-04-13       Impact factor: 3.676

2.  Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.

Authors:  Lília R Cordeiro Pedrosa; Albert van Hell; Regine Süss; Wim J van Blitterswijk; Ann L B Seynhaeve; Wiggert A van Cappellen; Alexander M M Eggermont; Timo L M ten Hagen; Marcel Verheij; Gerben A Koning
Journal:  Pharm Res       Date:  2013-05-11       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.